Vaccine Therapy in Treating Patients With Stage IV Cutaneous Melanoma

Clinical trial NCT00074230 · COMPLETED

Trial details

NCT number: NCT00074230
Sponsor: University Hospital Erlangen
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2003-07-01
Primary completion: 2014-03-01
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.